Navigation Links
SDCRM Receives Highest Score in Three of Four Categories from CIRM on Part I of Major Facilities Grant Application
Date:1/18/2008

SAN DIEGO, Jan. 18 /PRNewswire/ -- The San Diego Consortium for Regenerative Medicine (SDCRM) today announced that it has received the highest score in three of four categories from the California Institute of Regenerative Medicine (CIRM) on Part I of the Major Facilities Grant Application.

SDCRM's application, which was submitted last October, earned scores of 99 for basic research and discovery, 95 for preclinical research, 94 for preclinical development and 93 for use and contribution. Each of the four areas was evaluated on a scale of one to 100. Scores were approved by the Independent Citizens' Oversight Committee (ICOC) on Jan. 16. The Part I application contained information about SDCRM's scientific program, including the consortium's focus on the areas of neuroscience, hematopoiesis, heart disease, ophthalmic diseases and diabetes, among others.

California Institute for Regenerative Medicine

Summaries of Scientific Review Reports (Grants Working Group)

Major Facilities Grant RFA-07-03

Element

---------------------------

X Y Z

---------------------------

Pre-

clinical

Research Use &

Translat- & contribu-

Application Application Basic ional Develop- tion

# Organization Type Research Research ment Score

FA1-00607-1 SDCRM Institute 99 95 94 93

FA1-00609-1 Stanford

University Institute 96 95 91 95

FA1-00612-1 UC, Irvine Institute 94 94 90 92

FA1-00613-1 UCLA Institute 90 81 89 90

FA1-00616-1 UC, Santa

Barbara Institute 90 81 89 70

FA1-00617-1 UC, Santa Cruz Institute 90 81 89 84

FA1-00618-1 UC, San

Francisco Institute 90 81 89 92

FA1-00619-1 USC Institute 90 81 89 80

FA1-00611-1 UC, Davis Institute 85 90 83 88

FA1-00600-1 The Buck

Institute for

Age Research Center 81 85 83

FA1-00610-1 UC, Berkeley Center 80 75 80

FA1-00614-1 UC, Merced Program 72 71

"We are pleased that CIRM and the ICOC recognize the advantages of this type of collaboration and the need for a centralized location to conduct and translate research," said Edward Holmes, M.D., SDCRM's President and CEO. "This facility will enable the outstanding investigators who have and will join SDCRM to pursue the type of stem cell research that leads to breakthroughs in our understanding of human disease and where results with the greatest potential to help patients are translated into new therapies."

SDCRM will submit Part II of the Major Facility Grant Application, which contains technical information about the facility and how SDCRM's scientific program aligns with CIRM's objectives, in February. ICOC review and ultimate funding decisions will take place in April of this year.

About SDCRM

Formed in 2005, the San Diego Consortium for Regenerative Medicine (SDCRM) is a nonprofit organization that marshals the intellectual resources of four world-leaders in life sciences research, including the Burnham Institute for Medical Research, the Salk Institute for Biological Studies, The Scripps Research Institute and the University of California, San Diego. In addition to the collective strength of its members, SDCRM's research program goals are to invent research tools and technologies to hasten the pace of stem cell research progress and to discover and develop diagnostics, therapies and cures to relieve human suffering from chronic disease and injury.

Contact: Tracey Milani or David Schull

Russo Partners

619-814-3511

tracey.milani@russopartnersllc.com

david.schull@russopartnersllc.com


'/>"/>
SOURCE The San Diego Consortium for Regenerative Medicine
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
2. Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
3. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
4. Genta Receives Notice of Non-Compliance With NASDAQ Rule
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
7. EaglePicher Technologies Receives Battery Power Products and Technologys First Annual Innova Award
8. Aida Receives Chinese Government Innovation Award
9. Three Palm Software Receives FDA 510(k) Clearance for Its WorkstationOne(TM) Breast Imaging Workstation
10. Genta Receives NASDAQ Non-Compliance Notice
11. Tapestry Receives Notice Regarding Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... its flagship CytoSorb® blood filter to treat deadly ... the world, announced that CEO Dr. Phillip ... Source Capital Group,s 2016 Disruptive Growth & Healthcare ... company.  Conference Presentation Details: ...
(Date:2/4/2016)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... held February 8-9, 2016, at the Waldorf Astoria New ... Healthcare Conference, taking place in New York ... Sapirstein , Chief Executive Officer of ContraVir, will provide ...
(Date:2/4/2016)... ... 04, 2016 , ... Franz Inc. , an early ... has been recognized As “ Best in Semantic Web Technology - USA & ... America, it’s our priority to showcase prominent professionals who are excelling in their ...
(Date:2/3/2016)... SAN DIEGO , Feb. 3, 2016 /PRNewswire/ ... medicine company with the first pluripotent stem cell-derived ... 1 diabetes in clinical-stage development, today announced that ... Janssen Pharmaceutical Companies of Johnson & Johnson, have ... BetaLogics group into ViaCyte.  The agreement provides ViaCyte ...
Breaking Biology Technology:
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
(Date:1/18/2016)... Calif. , Jan. 18, 2016  Extenua ... software that simplifies the use and access of ... and go-to-market partnership with American Cyber.  ... brings extensive experience leading transformational C4ISR and Cyber ... and integrating the latest proven technology solutions," said ...
(Date:1/11/2016)... 11, 2016 Synaptics Incorporated (NASDAQ: SYNA ... announced that its ClearPad ® TouchView ™ ... two separate categories in the 8 th Annual ... Technology Breakthrough. The Synaptics ® TDDI solution enables ... chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):